Related references
Note: Only part of the references are listed.P2X7 receptor activation impairs antitumour activity of natural killer cells
Alberto Baroja-Mazo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2023)
P2X7 receptor antagonism by AZ10606120 significantly reduced in vitro tumour growth in human glioblastoma
Liyen K. Kan et al.
SCIENTIFIC REPORTS (2023)
P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer
Stephan Ledderose et al.
CANCERS (2023)
SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties
Michael C. Warren et al.
ImmunoHorizons (2023)
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7
Veronika Bandara et al.
NATURE COMMUNICATIONS (2023)
Recent progress in the structural biology of P2X receptors
Danqi Sheng et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2022)
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study
Paolo Andrea Zucali et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Design and synthesis of adamantane-1-carbonyl thiourea derivatives as potent and selective inhibitors of h-P2X4 and h-P2X7 receptors: An Emerging therapeutic tool for treatment of inflammation and neurological disorder
Abid Mahmood et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
High P2X6 receptor expression in human bladder cancer predicts good survival prognosis
Fabricia Dietrich et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2022)
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer
Erik Wennerberg et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
P2RX7 Enhances Tumor Control by CD8+ T Cells in Adoptive Cell Therapy
Kelsey M. Wanhainen et al.
CANCER IMMUNOLOGY RESEARCH (2022)
The ART of tumor immune escape
Erik Wennerberg et al.
ONCOIMMUNOLOGY (2022)
P2X7 is expressed on human innate-like T lymphocytes and mediates susceptibility to ATP-induced cell death
Riekje Winzer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2022)
Clinical implications of T cell exhaustion for cancer immunotherapy
Andrew Chow et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
M. Simonelli et al.
ESMO OPEN (2022)
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30
Peter Illes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Discovery of bilirubin as novel P2X7R antagonist with anti-tumor activity
Yunshuo Zhao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
P2X7 Variants in Oncogenesis
Anna Pegoraro et al.
CELLS (2021)
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy
Laetitia Douguet et al.
NATURE COMMUNICATIONS (2021)
P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells
Anna Pegoraro et al.
CELL DEATH & DISEASE (2021)
PI3K/Akt/GSK-3? signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells*
Wen-Jun Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer
Matthew Drill et al.
PURINERGIC SIGNALLING (2021)
The P2X7 Receptor in Microglial Cells Modulates the Endolysosomal Axis, Autophagy, and Phagocytosis
Keith E. Campagno et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches
Paul R. Territo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
P2X7 receptor as an independent prognostic indicator in gastric cancer
Ilknur Calik et al.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES (2020)
CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection
Erik Wennerberg et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Control of Metastases via Myeloid CD39 and NK Cell Effector Function
Juming Yan et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Astrocytes and Microglia Are Resistant to NAD+-Mediated Cell Death Along the ARTC2/P2X7 Axis
Bjoern Rissiek et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Evolutionary Origin of the P2X7 C-ter Region: Capture of an Ancient Ballast Domain by a P2X4-Like Gene in Ancient Jawed Vertebrates
Airi Rump et al.
FRONTIERS IN IMMUNOLOGY (2020)
P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors
Andrea Romagnani et al.
CANCER RESEARCH (2020)
P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
Romain Lara et al.
FRONTIERS IN PHARMACOLOGY (2020)
P2X7 Receptor at the Crossroads of T Cell Fate
Elizabeth Rivas-Yanez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The P2X7 Receptor as Regulator of T Cell Development and Function
Fabio Grassi
FRONTIERS IN IMMUNOLOGY (2020)
The P2X7 purinergic receptor: a potential therapeutic target for lung cancer
Qianqian Li et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Blocking P2X7-Mediated Macrophage Polarization Overcomes Treatment Resistance in Lung Cancer
Juliang Qin et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Structural and Functional Basis for Understanding the Biological Significance of P2X7 Receptor
Maria Angeles Martinez-Cuesta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
P2RX7B is a new theranostic marker for lung adenocarcinoma patients
Jonathan Benzaquen et al.
THERANOSTICS (2020)
ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival
S. M. Gilbert et al.
ONCOGENE (2019)
ARTC2.2/P2RX7 Signaling during Cell Isolation Distorts Function and Quantification of Tissue-Resident CD8+ T Cell and Invariant NKT Subsets
Henrique Borges da Silva et al.
JOURNAL OF IMMUNOLOGY (2019)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Extracellular ATP activates P2X7R-NF-κB (p65) pathway to promote the maturation of bone marrow-derived dendritic cells of mice
Ying Yu et al.
CYTOKINE (2019)
Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
Jonathan Benzaquen et al.
BIOMEDICAL JOURNAL (2019)
The role of P2X7 receptor in prognosis and metastasis of colorectal cancer
Ying Zhang et al.
ADVANCES IN MEDICAL SCIENCES (2019)
CD8+, but not CD4+ effector/memory T cells, express the CD44highCD45RBhigh phenotype with aging, which displays reduced expression levels of P2X7 receptor and ATP-induced cellular responses
Amine Mellouk et al.
FASEB JOURNAL (2019)
The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment
Elena De Marchi et al.
ONCOGENE (2019)
Blocking the ART2.2/P2X7-system is essential to avoid a detrimental bias in functional CD4 Tcell studies
Hristo Georgiev et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Activating P2X7 Receptors Increases Proliferation of Human Pancreatic Cancer Cells via ERK1/2 and JNK
Ji Hun Choi et al.
PANCREAS (2018)
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Thomas Duhen et al.
NATURE COMMUNICATIONS (2018)
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
Limo Chen et al.
CANCER DISCOVERY (2018)
The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Luiz E. B. Savio et al.
FRONTIERS IN PHARMACOLOGY (2018)
Variations in Cellular Responses of Mouse T cells to Adenosine-5′-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage
Hanaa Safya et al.
FRONTIERS IN IMMUNOLOGY (2018)
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni et al.
NATURE (2018)
The purinergic receptor P2RX7 directs metabolic fitness of long-lived memory CD8+ T cells
Henrique Borges da Silva et al.
NATURE (2018)
The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
Xiaohong Cen et al.
FRONTIERS IN PHARMACOLOGY (2018)
TRM maintenance is regulated by tissue damage via P2RX7
Regina Stark et al.
SCIENCE IMMUNOLOGY (2018)
Differential role of pannexin-1/ATP/P2X7 axis in IL-1β release by human monocytes
Katarzyna Parzych et al.
FASEB JOURNAL (2017)
The P2X7 Receptor in Infection and Inflammation
Francesco Di Virgilio et al.
IMMUNITY (2017)
ATP promotes the fast migration of dendritic cells through the activity of pannexin 1 channels and P2X7 receptors
Pablo J. Saez et al.
SCIENCE SIGNALING (2017)
Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer
Altaf Mohammed et al.
ONCOTARGET (2017)
ATP promotes the fast migration of dendritic cells through the activity of pannexin 1 channels and P2X7 receptors
Pablo J. Saez et al.
SCIENCE SIGNALING (2017)
Concurrent PD-1 Blockade Negates the Effects of OX40 Agonist Antibody in Combination Immunotherapy through Inducing T-cell Apoptosis
Rajeev K. Shrimali et al.
CANCER IMMUNOLOGY RESEARCH (2017)
ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells
Mariangela Lecciso et al.
FRONTIERS IN IMMUNOLOGY (2017)
A phase I clinical trial demonstrates that nfP2X7-targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma
S. M. Gilbert et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Evaluation of the expression and function of the P2X7 receptor and ART1 in human regulatory T-cell subsets
Juan D. Cortes-Garcia et al.
IMMUNOBIOLOGY (2016)
Purinergic Signaling as a Regulator of Th17 Cell Plasticity
Dominique Fernandez et al.
PLOS ONE (2016)
Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process
Carlos de Torre-Minguela et al.
SCIENTIFIC REPORTS (2016)
Purinergic signaling in the immune system
Francesco Di Virgilio et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2015)
P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma
Zheng Liu et al.
CANCER SCIENCE (2015)
The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma
F. Amoroso et al.
ONCOGENE (2015)
P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway
Jiyi Xia et al.
ONCOLOGY REPORTS (2015)
Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells
Iolanda D'Alimonte et al.
PURINERGIC SIGNALLING (2015)
Prognostic value of purinergic P2X7 receptor expression in patients with hepatocellular carcinoma after curative resection
Haiou Liu et al.
TUMOR BIOLOGY (2015)
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
Elena Adinolfi et al.
CANCER RESEARCH (2015)
P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value
Laura Boldrini et al.
ONCOLOGY LETTERS (2015)
The P2X7 receptor: Shifting from a low- to a high-conductance channel - An enigmatic phenomenon?
Luiz Anastacio Alves et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Adenosine triphosphate acts as a paracrine signaling molecule to reduce the motility of T cells
Chiuhui Mary Wang et al.
EMBO JOURNAL (2014)
P2X7 Mediates ATP-Driven Invasiveness in Prostate Cancer Cells
Ying Qiu et al.
PLOS ONE (2014)
Natural compounds with P2X7 receptor-modulating properties
Wolfgang Fischer et al.
PURINERGIC SIGNALLING (2014)
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment
G. Bianchi et al.
CELL DEATH & DISEASE (2014)
Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects
Zahid Ali et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors
Bilel Jelassi et al.
CARCINOGENESIS (2013)
Signaling through Purinergic Receptors for ATP Induces Human Cutaneous Innate and Adaptive Th17 Responses: Implications in the Pathogenesis of Psoriasis
Meaghan E. Killeen et al.
JOURNAL OF IMMUNOLOGY (2013)
Heteromeric assembly of P2X subunits
Anika Saul et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
P2X Receptors as Drug Targets
R. Alan North et al.
MOLECULAR PHARMACOLOGY (2013)
Expression of P2X7 Receptor Increases In Vivo Tumor Growth
Elena Adinolfi et al.
CANCER RESEARCH (2012)
Extracellular ATP Exerts Opposite Effects on Activated and Regulatory CD4+ T Cells via Purinergic P2 Receptor Activation
Sara Trabanelli et al.
JOURNAL OF IMMUNOLOGY (2012)
MECHANISMS OF DISEASE Purinergic Signaling during Inflammation
Holger K. Eltzschig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Alternative Splicing of the N-Terminal Cytosolic and Transmembrane Domains of P2X7 Controls Gating of the Ion Channel by ADP-Ribosylation
Nicole Schwarz et al.
PLOS ONE (2012)
The P2X7 Receptor Supports Both Life and Death in Fibrogenic Pancreatic Stellate Cells
Kristian A. Haanes et al.
PLOS ONE (2012)
P2X7 receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness
B. Jelassi et al.
ONCOGENE (2011)
ATP Inhibits the Generation and Function of Regulatory T Cells Through the Activation of Purinergic P2X Receptors
Ursula Schenk et al.
SCIENCE SIGNALING (2011)
Pyroptosis - a cell death modality of its kind?
Oliver Kepp et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetes
Felix Scheuplein et al.
JOURNAL OF AUTOIMMUNITY (2010)
Molecular Mechanism of NLRP3 Inflammasome Activation
Chengcheng Jin et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway
Sandra Hubert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
P2X7-mediated chemoprevention of epithelial cancers
George I. Gorodeski
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors
Andrea Babelova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The P2X7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X7R Pore
Mastura Monif et al.
JOURNAL OF NEUROSCIENCE (2009)
ADAMs 10 and 17 Represent Differentially Regulated Components of a General Shedding Machinery for Membrane Proteins Such as Transforming Growth Factor α, L-Selectin, and Tumor Necrosis Factor α
Sylvain M. Le Gall et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Effect of extracellular ATP on the growth of hormone-refractory prostate cancer in vivo
Majid Shabbir et al.
BJU INTERNATIONAL (2008)
Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse
Pilar Munoz et al.
BLOOD (2008)
ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site
Sahil Adriouch et al.
FASEB JOURNAL (2008)
Purinergic Control of T Cell Activation by ATP Released Through Pannexin-1 Hemichannels
Ursula Schenk et al.
SCIENCE SIGNALING (2008)
The unusual state-dependent affinity of P2X(3) receptors can be explained by an allosteric two-open-state model
R. Karoly et al.
MOLECULAR PHARMACOLOGY (2008)
NAD+ released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo
Sahil Adriouch et al.
JOURNAL OF IMMUNOLOGY (2007)
Chemotactic activity of extracellular nucleotides on human immune cells
Daniel Myrtek et al.
PURINERGIC SIGNALLING (2007)
Extracellular NAD and ATP: Partners in immune cell modulation
Friedrich Haag et al.
PURINERGIC SIGNALLING (2007)
Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor
Pablo Pelegrin et al.
EMBO JOURNAL (2006)
P2X receptors as cell-surface ATP sensors in health and disease
Baljit S. Khakh et al.
NATURE (2006)
ADP-ribosyltransferase-specific modification of human neutrophil peptide-1
Gregorino Paone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines
C Sandoval-Montes et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
CD38 controls ADP-ribosyltransferase-2-catalyzed ADP-ribosylation of T cell surface proteins
C Krebs et al.
JOURNAL OF IMMUNOLOGY (2005)
P2X7 receptor-dependent and -independent T cell death is induced by nicotinamide adenine dinucleotide
H Kawamura et al.
JOURNAL OF IMMUNOLOGY (2005)
NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor
M Seman et al.
IMMUNITY (2003)
Characteristics of ATP-induced current through P2X7 receptor in NG108-15 cells:: Unique antagonist sensitivity and lack of pore formation
T Watano et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2002)
Functional characterization of P2Y and P2X receptors in human eosinophils
M Idzko et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2001)
Adenosine triphosphate-induced oxygen radical production and CD11b up-regulation:: Ca++ mobilization and actin reorganization in human eosinophils
S Dichmann et al.
BLOOD (2000)
Share Paper
